Effect of right ventricular apical pacing in survivors of myocardial infarction

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue SUPPL. 1, 2009, Pages

  Muto, Carmine ^a   Ascione, Luigi ^a   Canciello, Michelangelo ^a   Carreras, Giovanni ^a   Iengo, Raffaele ^a   Ottaviano, Luca ^a   Calvanese, Raimondo ^a   Accadia, Maria ^a   Celentano, Eduardo ^a   Ciardiello, Carmine ^b,c   Tuccillo, Bernardino ^a  

^a Loreto Mare Hospital   (Italy)

^b Boston Scientific   (Italy)

^c Ospedale Loreto Mare ^*  (Italy)

Author keywords

Heart failure; Myocardial infarction; Permanent pacing; Right ventricular pacing

Indexed keywords

ADULT; AGED; ARTIFICIAL HEART PACEMAKER; BLOOD VOLUME; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART RIGHT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIAC PACING, ARTIFICIAL; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SURVIVORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 60849136029     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.02279.x     Document Type: Conference Paper

References (9)

1. Manolis AS. The deleterious consequences of right ventricular apical pacing: Time to seek alternate site pacing. Pacing Clin Electrophysiol 2006 29 : 298 315.
2. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA., for the MOde Selection Trial (MOST) Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003 107 : 2932 2937.
3. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 2002 288 : 3115 3123.
4. Sharma AD, Rizo-Patron C, Hallstrom AP, O'Neill GP, Rothbart S, Martins JB, Roelke M, et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005 2 : 830 834.
5. Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, Mcnitt S, Andrews M, et al. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol 2005 16 : 359 365.
6. Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, Roger VL. Heart failure and death after myocardial infarction in the community: The emerging role of mitral regurgitation. Circulation 2005 111 : 295 311.
7. Aronson D, Goldsher N, Zuckermann R, Kapeliovich M, Lessick J, Mutlak D, Dabbah S, et al. Ischemic mitral regurgitation and risk of heart failure after myocardial infarction. Arch Int Med 2006 166 : 2362 2368.
8. Barold SS, Ovsyshcher IE. Pacemaker-induced mitral regurgitation. Pacing Clin Electrophysiol 2005 28 : 357 360.
9. Muto C, Ottaviano L, Canciello M, Carreras G, Calvanese R, Ascione L, Iengo R, et al. Effect of pacing the right ventricular mid-septum tract in patients with permanent atrial fibrillation and low ejection fraction. J Cardiovasc Electrophysiol 2007 18 : 1032 1036.